Charles Schwab Investment Management Inc Opgen Inc Transaction History

Charles Schwab Investment Management Inc

  • $515 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.72 - $1.11 $16,272 - $25,086
-22,600 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.95 - $2.8 $44,070 - $63,279
22,600 New
22,600 $52,000

Others Institutions Holding OPGN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About OPGEN INC

OPGN Quotes by TradingView
  • Ticker OPGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,698,500
  • Market Cap $38.7M
  • Description
  • OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...
More about OPGN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email